OSE · OSE IMMUNOTHERAPEUTICS · Documents
Market Cap
55.44M EUR
Shares
24.73M
OSE IMMUNOTHERAPEUTICS's financial reports and regulated publications, as filed with the market regulator, most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| ESEF Annual Report | 2026-06-11 | 2025-12-31 | |
| ESEF Annual Report | 2025-05-07 | 2024-12-31 |
Showing 1–2 of 2 filings
Official financial reports
Official annual, half-year and quarterly publication attachments from DILA / AMF. These are source links, not extracted financial figures. Publication dates are not reporting periods. One publication can have multiple attachments. Source revisions remain separate; do not treat every entry as a current report. Only captured publication months are covered, and gaps may exist. Freshness covers every captured month; CheckedAt is the oldest month check.
| Published (UTC) | Report | Type | Source revision |
|---|---|---|---|
| 2023-09-27 | RAPPORT FINANCIER SEMESTRIEL Français · 506823_20230927 | Half-year financial and audit report | NEW |
| 2022-09-22 | RAPPORT FINANCIER SEMESTRIEL Français · 458918_20220922 | Half-year financial and audit report | NEW |
| 2020-09-16 | RAPPORT FINANCIER SEMESTRIEL 30/06/2020 Français · 349631_20200917 | Half-year financial and audit report | NEW |
| 2019-09-05 | RAPPORT FINANCIER SEMESTRIEL Français · 296551_20190906 | Half-year financial and audit report | NEW |
| 2012-09-21 | RAPPORT FINANCIER SEMESTRIEL 30/06/2021 Français · 401405_20210921 | Half-year financial and audit report | NEW |
238 publication months captured between 2007-01 and 2026-10; gaps may exist. Oldest month check 2026-09-21 02:08 UTC.
Showing 1–5 of 5 publications